Today the German-American biotech company MediGene AG (Frankfurt, Prime Standard: MDG, TecDAX) has presented its 3-months report 2006. Total revenues increased by 73 % from 3.8 million € to 6.6 million €. Revenues include for the first time proceeds from the Polyphenon® E* partnership with Bradley Pharmaceuticals.
